In this issue:
Molnupiravir for oral treatment of Covid-19
Cardiovascular and cancer risk with tofacitinib in RA
Tofacitinib in JIA
Effect of intra-articular PRP on pain and medial tibial cartilage volume in knee OA
Effectiveness of belimumab after rituximab in SLE
Progression of patients with Raynaud's phenomenon to systemic sclerosis
Pathogenic and protective polyfunctional T-cell responses in RA
Joint inflammation tends to recur in the same joints during RA disease course
Flares after HCQ reduction or discontinuation in SLE
Digoxin targets LRP4 and protects against OA
Please login below to download this issue (PDF)